Congenital Heart

This Congenital Heart Disease channel includes news and new technology to diagnose, treat and manage congenital heart disease. This includes transposed vessels, tetralogy of Fallot, pediatric cardiomyopathy, pulmonary heart valves, pulmonary atresia, patent foramen ovale (PFO),  atrial septal defect (ASD) and ventricular septal defect (VSD). 

News | Congenital Heart

December 14, 2021 – The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) announces five awardees ...

Home December 14, 2021
Home
Videos | Structural Heart

Tom Jones, M.D., director, cardiac cath labs, Seattle Children’s Hospital, and principle investigator of the Medtronic ...

Home September 28, 2021
Home
Videos | Congenital Heart

Tom Jones, M.D., director, cardiac cath labs, Seattle Children’s Hospital, explains the importance of the heart team ...

Home September 15, 2021
Home
A comparison of color-flow Doppler cardiac ultrasound showing blood flow, and blood speckle tracking revealing a more detailed and complex understanding of the low. It shows the formation of a vortex that may play a role in future assessments for the efficiency of flow in the heart and vessels. #ASE21 #ASE2021 #Vectorflowimaging
Feature | Cardiac Imaging | By Dave Fornell, Editor

In the past several years, a few cardiac ultrasound vendors have developed new ways to image the intricate flow of ...

Home August 17, 2021
Home
Images or a digital twin mitral valve of a patient created from cardiac ultrasound that were used to perform a virtual surgical procedure to test how the intervention would impact the patient prior to actually performing the procedure. The right image shows color coding for sheer stresses on the valve leaflets before and after the virtual surgery. The right image shows the model quantitation of leaflet coaptation at peak systole prior to the the virtual surgery. Read the original article in Plos One https:/
Feature | Cardiovascular Ultrasound | By Dave Fornell, Editor

Outside of medicine, computer-generated virtual twins of real machines like cars or airplanes have been used in ...

Home July 26, 2021
Home
The Xeltis synthetic polymer restorative pulmonary valve is implanted surgically and acts as a scaffold for the patient's own cells to proliferate. The valve and conduit then bioresorbs over time, leaving behind a new valve made from the patient's own cells. The hope is this will reduce or eliminate the need for numerous repeat surgeries as a pediatric patient grows.
Feature | Heart Valve Technology

July 8, 2021 – Xeltis announced it started the first pivotal trial for a synthetic polymer restorative pulmonary valve ...

Home July 08, 2021
Home
News | Congenital Heart

June 29, 2021 – Echocardiography with ultrasound enhancing agents (UEAs) has proven to be a valuable imaging procedure ...

Home June 29, 2021
Home
Videos | Congenital Heart

Tom Jones, M.D., director, cardiac catheterization laboratories, Seattle Children’s Hospital, explains some of the new ...

Home May 26, 2021
Home
Videos | Structural Heart

Tom Jones, M.D., director, cardiac catheterization laboratories, Seattle Children’s Hospital, and principle investigator ...

Home May 13, 2021
Home
News | Congenital Heart

May 1, 2021 - An analysis of a new international registry reveals benefits of using a longer covered stent for ...

Home May 01, 2021
Home
The Medtronic Harmony transcatheter pulmonary valve (TPV) system offers a less invasive treatment option for patients with a congenital heart defect irregularity in their right ventricular outflow tract (RVOT) that requires a pulmonary valve placement to restore valve function. 
Feature | Structural Heart | Dave Fornell, Editor

April 30, 2021 — New study results validate the effectiveness of the Medtronic Harmony transcatheter pulmonary valve ...

Home April 30, 2021
Home
News | Structural Heart Occluders

April 20, 2021 — Start-up medical device company atHeart Medical announced it is initiating its U.S. investigational ...

Home April 20, 2021
Home
The Medtronic Harmony Transcatheter Pulmonary Valve (TPV) System. It is first in the world non-surgical heart valve to treat pediatric and adult patients with a native or surgically-repaired right ventricular outflow tract (RVOT) to stop severe pulmonary valve regurgitation caused by congenital heart disease.
Feature | Structural Heart | By Dave Fornell, Editor

March 26, 2021 — Today, the U.S. Food and Drug Administration (FDA) cleared the Medtronic Harmony Transcatheter ...

Home March 26, 2021
Home
News | Congenital Heart

March 24, 2021 — Congenital heart disease (CHD) affects six out of 1,000 babies born in the U.S. each year and is often ...

Home March 24, 2021
Home
Subscribe Now